Skip to main content

Table 4 Results validated by FDR < 0.05 cutoff limit

From: CRP gene variation affects early development of Alzheimer's disease-related plaques

p-value SNP (and genotype) or Haplotype Association
p< 0.0001 n/a Aβ IHC and CRP IHC stainings (Chi square)
p = 0.003 rs3093075 (genotype CA) Increased risk of non-neuritic SP
p = 0.007 rs3091244 (TA) Increased risk of non-neuritic SP
p = 0.007 Haplotype (6) TAGCC Increased risk of non-neuritic SP
p = 0.037 rs2794521 (CT) Reduced risk of non-neuritic SP
p = 0.076 rs1130864 (TT) Reduced risk of non-neuritic SP
p = 0.076 Haplotype (4) TCGCT Reduced risk of having NFT
p = 0.080 rs3093075 (CA) Increased risk of neuritic SP
p = 0.083 rs2794521 (CT) More likely to have CRP IHC staining
p = 0.087 rs3093075 (CA) Less likely to have CRP IHC staining
p = 0.090 Haplotype (6) TAGCC Less likely to have CRP IHC staining
p = 0.112 rs3091244 (TT) Reduced risk of non-neuritic SP
p = 0.118 rs2794521 (CT) Reduced risk of neuritic SP